NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle

Nucleic Acids Research

Volumn 38, Issue 10, 2010, Pages 3159-3171

  Heyne, Kristina ^a   Willnecker, Vivienne ^a   Schneider, Julia ^a   Conrad, Marcel ^a   Raulf, Nina ^a   Schüle, Roland ^b   Roemer, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; ENZYME INHIBITOR; HISTONE ACETYLTRANSFERASE; NOVEL INHIBITOR OF HISTONE ACETYLTRANSFERASE REPRESSOR; PROTEIN P21; PROTEIN P63; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NOC2L PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSACTIVATION; TRANSCRIPTION REGULATION; CELL CULTURE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; NUCLEOLUS; TRANSCRIPTION INITIATION;

CELL CYCLE; CELL NUCLEOLUS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HISTONE ACETYLTRANSFERASES; HUMANS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 77953708756     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq016     Document Type: Article

References (49)

1. Riley,T., Sontag,E., Chen,P. and Levine,A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell. Biol., 9, 402-412.
2. Candi,E., Dinsdale,D., Rufini,A., Salomoni,P., Knight,R.A., Mueller,M., Krammer,P.H. and Melino,G. (2007) TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle, 6, 274-285.
3. Flores,E.R. (2007) The roles of p63 in cancer. Cell Cycle, 6, 300-304.
4. McKeon,F. and Melino,G. (2007) Fog of war: the emerging p53 family. Cell Cycle, 6, 229-232.
5. Rinne,T., Brunner,H.G. and van Bokhoven,H. (2007) p63-associated disorders. Cell Cycle, 6, 262-268.
6. Osada,M., Park,H.L., Nagakawa,Y., Yamashita,K., Fomenkov,A., Kim,M.S., Wu,G., Nomoto,S., Trink,B. and Sidransky,D. (2005) Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol., 25, 6077-6089.
7. Perez,C.A. and Pietenpol,J.A. (2007) Transcriptional programs regulated by p63 in normal epithelium and tumors. Cell Cycle, 6, 246-254.
8. Vigano,M.A. and Mantovani,R. (2007) Hitting the numbers: the emerging network of p63 targets. Cell Cycle, 6, 233-239.
9. Wu,G., Nomoto,S., Hoque,M.O., Dracheva,T., Osada,M., Lee,C.C., Dong,S.M., Guo,Z., Benoit,N., Cohen,Y. et al. (2003) DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res., 63, 2351-2357.
10. Carroll,D.K., Carroll,J.S., Leong,C.O., Cheng,F., Brown,M., Mills,A.A., Brugge,J.S. and Ellisen,L.W. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell. Biol., 8, 551-561.
11. Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C. (2006) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ., 13, 962-972.
12. Yang,A., Zhu,Z., Kapranov,P., McKeon,F., Church,G.M., Gingeras,T.R. and Struhl,K. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell, 24, 593-602.
13. Trink,B., Osada,M., Ratovitski,E. and Sidransky,D. (2007) p63 transcriptional regulation of epithelial integrity and cancer. Cell Cycle, 6, 240-245.
14. Yi,R., Poy,M.N., Stoffel,M. and Fuchs,E. (2008) A skin microRNA promotes differentiation by repressing 'stemness'. Nature, 452, 225-229.
15. Mikkola,M.L. (2007) p63 in skin appendage development. Cell Cycle, 6, 285-290.
16. Truong,A.B., Kretz,M., Ridky,T.W., Kimmel,R. and Khavari,P.A. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev., 20, 3185-3197.
17. Koster,M.I., Dai,D. and Roop,D.R. (2007) Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle, 6, 269-273.
18. Miller,F.D. and Kaplan,D.R. (2007) To die or not to die: neurons and p63. Cell Cycle, 6, 312-317.
19. Wang,L., Tang,Y., Cole,P.A. and Marmorstein,R. (2008) Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr. Opin. Struct. Biol., 18, 741-747.
20. Ghosh,A.K. and Varga,J. (2007) The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J. Cell. Physiol., 213, 663-671.
21. Kalkhoven,E. (2004) CBP and p300: HATs for different occasions. Biochem. Pharmacol., 68, 1145-1155.
22. MacPartlin,M., Zeng,S., Lee,H., Stauffer,D., Jin,Y., Thayer,M. and Lu,H. (2005) p300 regulates p63 transcriptional activity. J. Biol. Chem., 280, 30604-30610.
23. Avantaggiati,M.L., Ogryzko,V., Gardner,K., Giordano,A., Levine,A.S. and Kelly,K. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89, 1175-1184.
24. Gu,W., Roeder,R.G. and Shi,X.L. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
25. Lill,N.L., Grossman,S.R., Ginsberg,D., DeCaprio,J. and Livingston,D.M. (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature, 387, 823-827.
26. Zeng,X., Li,X., Miller,A., Yuan,Z., Yuan,W., Kwok,R.P., Goodman,R., Lu,H., Goodman,R.H. and Smolik,S. (2000) The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell. Biol., 20, 1299-1310.
27. Gu,W. and Roeder,R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
28. Zeng,X., Lee,H., Zhang,Q. and Lu,H. (2001) p300 does not require its acetylase activity to stimulate p73 function. J. Biol. Chem., 276, 48-52.
29. Costanzo,A., Merlo,P., Pediconi,N., Fulco,M., Sartorelli,V., Cole,P.A., Fontemaggi,G., Fanciulli,M., Schiltz,L., Blandino,G. et al. (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell, 9, 175-186.
30. Hublitz,P., Kunowska,N., Mayer,U.P., Muller,J.M., Heyne,K., Yin,N., Fritzsche,C., Poli,C., Miguet,L., Schupp,I.W. et al. (2005) NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev., 19, 2912-2924.
31. Seo,S.B., McNamara,P., Heo,S., Turner,A., Lane,W.S. and Chakravarti,D. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell, 104, 119-130.
32. Seo,S.B., Macfarlan,T., McNamara,P., Hong,R., Mukai,Y., Heo,S. and Chakravarti,D. (2002) Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J. Biol. Chem., 277, 14005-14010.
33. Schneider,R., Bannister,A.J., Weise,C. and Kouzarides,T. (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J. Biol. Chem., 279, 23859-23862.
34. Kutney,S.N., Hong,R., Macfarlan,T. and Chakravarti,D. (2004) A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J. Biol. Chem., 279, 30850-30855.
35. Mayer,C. and Grummt,I. (2005) Cellular stress and nucleolar function. Cell Cycle, 4, 1036-1038.
36. Bornkamm,G.W., Berens,C., Kuklik-Roos,C., Bechet,J.M., Laux,G., Bachl,J., Korndoerfer,M., Schlee,M., Holzel,M., Malamoussi,A. et al. (2005) Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res., 33, e137.
37. Gautier,T., Robert-Nicoud,M., Guilly,M.N. and Hernandez-Verdun,D. (1992) Relocation of nucleolar proteins around chromosomes at mitosis. A study by confocal laser scanning microscopy. J. Cell. Sci., 102, 729-737.
38. Brandl,A., Heinzel,T. and Kramer,O.H. (2009) Histone deacetylases: salesmen and customers in the post-translational modification market. Biol. Cell, 101, 193-205.
39. Bunz,F., Hwang,P.M., Torrance,C., Waldman,T., Zhang,Y., Dillehay,L., Williams,J., Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest., 104, 263-269.
40. Mahyar-Roemer,M. and Roemer,K. (2001) p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene, 20, 3387-3398.
41. Mills,A.A., Zheng,B., Wang,X.J., Vogel,H., Roop,D.R. and Bradley,A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
42. Yang,A., Schweitzer,R., Sun,D., Kaghad,M., Walker,N., Bronson,R.T., Tabin,C., Sharpe,A., Caput,D., Crum,C. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
43. Yang,A., Kaghad,M., Wang,Y., Gillett,E., Fleming,M.D., Dotsch,V., Andrews,N.C., Caput,D. and McKeon,F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-316.
44. Lee,H. and Kimelman,D. (2002) A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell, 2, 607-616.
45. Nylander,K., Vojtesek,B., Nenutil,R., Lindgren,B., Roos,G., Zhanxiang,W., Sjostrom,B., Dahlqvist,A. and Coates,P.J. (2002) Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol., 198, 417-427.
46. Pruneri,G., Fabris,S., Dell'Orto,P., Biasi,M.O., Valentini,S., Del Curto,B., Laszlo,D., Cattaneo,L., Fasani,R., Rossini,L. et al. (2005) The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification. J. Pathol., 206, 337-345.
47. Feuerstein,N., Chan,P.K. and Mond,J.J. (1988) Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J. Biol. Chem., 263, 10608-10612.
48. Li,J., Zhang,X., Sejas,D.P. and Pang,Q. (2005) Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leuk. Res., 29, 1415-1423.
49. Grisendi,S., Bernardi,R., Rossi,M., Cheng,K., Khandker,L., Manova,K. and Pandolfi,P.P. (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature, 437, 147-153.